• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环miRNA-202-3p是诊断1型胃神经内分泌肿瘤的一种潜在新型生物标志物。

Circulating miRNA-202-3p is a potential novel biomarker for diagnosis of type 1 gastric neuroendocrine neoplasms.

作者信息

Dou Dou, Li Xiao-Kou, Xia Qi-Sheng, Chen Ying-Ying, Li Yuan-Liang, Wang Chao, Qi Zhi-Rong, Tan Huang-Ying

机构信息

Beijing University of Chinese Medicine, Beijing, China.

Department of Integrative Oncology, China-Japan Friendship Hospital, Beijing, China.

出版信息

BMC Gastroenterol. 2021 Apr 23;21(1):188. doi: 10.1186/s12876-021-01769-7.

DOI:10.1186/s12876-021-01769-7
PMID:33892648
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8066967/
Abstract

BACKGROUND

Currently, there are no circulating diagnostic biomarkers for gastric neuroendocrine neoplasms (g-NENs). In previous studies, we found that miRNA-202-3p is overexpressed in the tumour tissue of type 1 g-NEN. We speculated that miRNA-202-3p is also likely to be highly expressed in circulating blood.

METHODS

A total of 27 patients with type 1 g-NEN and 27 age- and sex-matched control participants were enrolled in this study. The miRNA-202-3p levels in serum obtained from the participants were measured by qRT-PCR. The expression level of miRNA-202-3p in the samples was calculated by comparison with a standard curve.

RESULTS

The clinical characteristics of the patients were similar to those of the patient samples in previous reports. Expression of miRNA-202-3p was significantly higher in the patient group (3.84 × 10 copies/nl) than in the control group (0.635 × 10 copies/nl). The area under the ROC curve (AUC) was 0.878 (95% CI: 0.788-0.968), and the optimal cut-off point was approximately 1.12 × 10 copies/nl. The sensitivity and specificity were 88.9% and 77.8%, respectively.

CONCLUSION

This study suggests that miRNA-202-3p is potentially useful as a biomarker of type 1 g-NEN; further investigation and verification should be performed in future research.

摘要

背景

目前,尚无用于胃神经内分泌肿瘤(g-NENs)的循环诊断生物标志物。在先前的研究中,我们发现miRNA-202-3p在1型g-NEN的肿瘤组织中过表达。我们推测miRNA-202-3p在循环血液中也可能高表达。

方法

本研究共纳入27例1型g-NEN患者和27名年龄及性别匹配的对照参与者。通过qRT-PCR检测参与者血清中的miRNA-202-3p水平。通过与标准曲线比较计算样本中miRNA-202-3p的表达水平。

结果

患者的临床特征与先前报道中的患者样本相似。miRNA-202-3p在患者组中的表达(3.84×10拷贝/纳升)显著高于对照组(0.635×10拷贝/纳升)。ROC曲线下面积(AUC)为0.878(95%CI:0.788 - 0.968),最佳截断点约为1.12×10拷贝/纳升。敏感性和特异性分别为88.9%和77.8%。

结论

本研究表明,miRNA-202-3p可能作为1型g-NEN的生物标志物;未来研究应进行进一步的调查和验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e52/8066967/8cc68af93fac/12876_2021_1769_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e52/8066967/95a895cf79c4/12876_2021_1769_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e52/8066967/8cc68af93fac/12876_2021_1769_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e52/8066967/95a895cf79c4/12876_2021_1769_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e52/8066967/8cc68af93fac/12876_2021_1769_Fig2_HTML.jpg

相似文献

1
Circulating miRNA-202-3p is a potential novel biomarker for diagnosis of type 1 gastric neuroendocrine neoplasms.循环miRNA-202-3p是诊断1型胃神经内分泌肿瘤的一种潜在新型生物标志物。
BMC Gastroenterol. 2021 Apr 23;21(1):188. doi: 10.1186/s12876-021-01769-7.
2
Hsa-miR-202-3p, up-regulated in type 1 gastric neuroendocrine neoplasms, may target .Hsa-miR-202-3p 在 1 型胃神经内分泌肿瘤中上调,可能靶向.
World J Gastroenterol. 2018 Feb 7;24(5):573-582. doi: 10.3748/wjg.v24.i5.573.
3
Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.血浆 microRNAs 作为早期胃癌早期检测的潜在新型生物标志物。
World J Gastroenterol. 2019 Apr 7;25(13):1580-1591. doi: 10.3748/wjg.v25.i13.1580.
4
Serum miR-515-3p, a potential new RNA biomarker, is involved in gastric carcinoma.血清 miR-515-3p,一种潜在的新型 RNA 生物标志物,参与胃癌的发生。
J Cell Biochem. 2019 Sep;120(9):15834-15843. doi: 10.1002/jcb.28854. Epub 2019 May 12.
5
MiRNA-199a-3p: A potential circulating diagnostic biomarker for early gastric cancer.miRNA-199a-3p:一种用于早期胃癌的潜在循环诊断生物标志物。
J Surg Oncol. 2013 Aug;108(2):89-92. doi: 10.1002/jso.23358. Epub 2013 Jun 3.
6
Five serum-based miRNAs were identified as potential diagnostic biomarkers in gastric cardia adenocarcinoma.五项血清 miRNA 被鉴定为胃贲门腺癌的潜在诊断生物标志物。
Cancer Biomark. 2018;23(2):193-203. doi: 10.3233/CBM-181258.
7
miRNA-199a-3p in plasma as a potential diagnostic biomarker for gastric cancer.血浆中的 miRNA-199a-3p 作为胃癌的潜在诊断生物标志物。
Ann Surg Oncol. 2013 Dec;20 Suppl 3:S397-405. doi: 10.1245/s10434-012-2600-3. Epub 2012 Sep 7.
8
Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis.鉴定血清中六miRNA 标志物panel 有益于胰腺癌诊断。
Cancer Med. 2019 Jun;8(6):2810-2822. doi: 10.1002/cam4.2145. Epub 2019 Apr 21.
9
Overexpression of MicroRNA miR-7-5p Is a Potential Biomarker in Neuroendocrine Neoplasms of the Small Intestine.miR-7-5p 的过表达是小肠神经内分泌肿瘤的一个潜在的生物标志物。
Neuroendocrinology. 2018;106(4):312-317. doi: 10.1159/000480121. Epub 2017 Aug 19.
10
Six Serum-Based miRNAs as Potential Diagnostic Biomarkers for Gastric Cancer.六种基于血清的微小RNA作为胃癌潜在的诊断生物标志物
Cancer Epidemiol Biomarkers Prev. 2017 Feb;26(2):188-196. doi: 10.1158/1055-9965.EPI-16-0607. Epub 2016 Oct 18.

引用本文的文献

1
Identification of combinatorial miRNA panels derived from extracellular vesicles as biomarkers for esophageal squamous cell carcinoma.鉴定源自细胞外囊泡的组合微小RNA(miRNA)面板作为食管鳞状细胞癌的生物标志物。
MedComm (2020). 2023 Sep 18;4(5):e377. doi: 10.1002/mco2.377. eCollection 2023 Oct.
2
MiR-202-3p inhibits the proliferation and metastasis of lung adenocarcinoma cells by targeting RRM2.微小RNA-202-3p通过靶向核糖核苷酸还原酶M2亚基抑制肺腺癌细胞的增殖和转移。
Ann Transl Med. 2022 Dec;10(24):1374. doi: 10.21037/atm-22-6089.

本文引用的文献

1
A Prospective and Retrospective Clinical Controlled Observation of Chinese Herbal Decoction (SMLJ01) for Type 1 Gastric Neuroendocrine Tumors.中药复方 SMLJ01 治疗胃神经内分泌肿瘤 1 型的前瞻性和回顾性临床对照观察
Integr Cancer Ther. 2020 Jan-Dec;19:1534735420958488. doi: 10.1177/1534735420958488.
2
The 2019 WHO classification of tumours of the digestive system.2019年世界卫生组织消化系统肿瘤分类。
Histopathology. 2020 Jan;76(2):182-188. doi: 10.1111/his.13975. Epub 2019 Nov 13.
3
The NETest: The Clinical Utility of Multigene Blood Analysis in the Diagnosis and Management of Neuroendocrine Tumors.
NETest:多基因血液分析在神经内分泌肿瘤诊断和治疗中的临床应用。
Endocrinol Metab Clin North Am. 2018 Sep;47(3):485-504. doi: 10.1016/j.ecl.2018.05.002.
4
Hsa-miR-202-3p, up-regulated in type 1 gastric neuroendocrine neoplasms, may target .Hsa-miR-202-3p 在 1 型胃神经内分泌肿瘤中上调,可能靶向.
World J Gastroenterol. 2018 Feb 7;24(5):573-582. doi: 10.3748/wjg.v24.i5.573.
5
Profiling of metastatic small intestine neuroendocrine tumors reveals characteristic miRNAs detectable in plasma.转移性小肠神经内分泌肿瘤的分析揭示了可在血浆中检测到的特征性微小RNA。
Oncotarget. 2017 Apr 7;8(33):54331-54344. doi: 10.18632/oncotarget.16908. eCollection 2017 Aug 15.
6
[Analysis of primary site and pathology on 903 patients with neuroendocrine neoplasms].903例神经内分泌肿瘤患者的原发部位及病理分析
Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Sep 25;20(9):993-996.
7
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.美国神经内分泌肿瘤患者的发病率、患病率和生存结局趋势。
JAMA Oncol. 2017 Oct 1;3(10):1335-1342. doi: 10.1001/jamaoncol.2017.0589.
8
Gastrin-induced miR-222 promotes gastric tumor development by suppressing p27kip1.胃泌素诱导的miR-222通过抑制p27kip1促进胃肿瘤发展。
Oncotarget. 2016 Jul 19;7(29):45462-45478. doi: 10.18632/oncotarget.9990.
9
MiR-202 promotes endometriosis by regulating SOX6 expression.微小RNA-202通过调节SOX6的表达促进子宫内膜异位症。
Int J Clin Exp Med. 2015 Oct 15;8(10):17757-64. eCollection 2015.
10
Somatostatin Analogs Treated Small Intestinal Neuroendocrine Tumor Patients Circulating MicroRNAs.生长抑素类似物治疗小肠神经内分泌肿瘤患者的循环微小RNA
PLoS One. 2015 May 5;10(5):e0125553. doi: 10.1371/journal.pone.0125553. eCollection 2015.